Paola Biason
0000-0002-2298-101X
Istituto Oncologico Veneto
28 papers found
Refreshing results…
UGT1A1*28 and Other UGT1A Polymorphisms as Determinants of Irinotecan Toxicity
UGT1A1*20 and other UGT1A polymorphisms as determinants of irinotecan toxicity
Pharmacology of epidermal growth factor inhibitors
597 POSTER MDM2 309T>G polymorphism in human sarcomas
The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer
Carboxylesterase Isoform 2 mRNA Expression in Peripheral Blood Mononuclear Cells Is a Predictive Marker of the Irinotecan to SN38 Activation Step in Colorectal Cancer Patients
Sarcomas and pharmacogenetics
Missing publications? Search for publications with a matching author name.